Known targets — ChEMBL curated mechanism
KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2
The experimentally established mechanism targets of Phenol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | CA3 | P07451 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.43 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.43 |
| ▸ | C1S | P09871 | 1/20 | 0.43 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | F10 | P00742 | 1/20 | 0.41 |
| ▸ | F12 | P00748 | 1/20 | 0.41 |
| ▸ | F7 | P08709 | 1/20 | 0.41 |
| ▸ | F3 | P13726 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenol SCHEMBL27571305 | 0.92 | CA12 (0.42) | CA12CA2CA3CA9CA14 | |
| Phenol SCHEMBL177595 | 0.92 | CA12 (0.42) | CA12CA2CA3CA9CA14 | |
| Phenol SCHEMBL1525247 | 0.88 | CA12 (0.65) | CA12CA2CA3CA9CA14 | |
| Phenol SCHEMBL447771 | 0.85 | CA12 (0.69) | CA12CA2CA3CA9CA14 | |
| Phenol SCHEMBL8354282 | 0.85 | CA12 (0.69) | CA12CA2CA3CA9CA14 | |
| Phenol SCHEMBL28497921 | 0.83 | CA12 (0.58) | CA12CA2CA3CA9CA14 | |
| Phenol SCHEMBL1921716 | 0.83 | CA12 (0.65) | CA12CA2CA3CA9CA14 | |
| Phenol SCHEMBL27501631 | 0.83 | CA12 (0.65) | CA12CA2CA3CA9CA14 | |
| Phenol SCHEMBL486710 | 0.79 | CA12 (0.52) | CA12CA2CA3CA9CA14 | |
| Phenol SCHEMBL546282 | 0.79 | CA12 (0.52) | CA12CA2CA3CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 410 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112986573-B | Quantitative detection method for exosome multi-group chemical markers | 深圳汇芯生物医疗科技有限公司 | 2023-05-02 | — | — | CN | claimed |
| CN-112986573-A | Quantitative detection method of exosome multigroup chemical marker | 深圳汇芯生物医疗科技有限公司 | 2021-06-18 | — | — | CN | claimed |
| WO-2004079333-A2 | METHOD AND KIT FOR EXTRACTING RNA FROM SPUTUM | IC & G CO., LTD. (KR) | 2004-09-16 | — | — | WO | claimed |
| US-6759217-B2 | DIAGNOSIS AND DETECTION OF CANCER; OBTAIN TISSUE SAMPLE, EXTRACT NUCLEOTIDE SEQUENCES, INCUBATE WITH PROBE PREFERENTIAL FOR TUMOR SEQUENCES, DETECT BINDING, BOUND PROBE INDICATES TUMORS | ONCOMEDX, INC. | 2004-07-06 | — | — | US | claimed |
| WO-2003028531-A2 | DETECTION OF TUMOR RNA IN PLASMA AND SERUM | ONCOMEDX, INC. (US) | 2003-04-10 | — | — | WO | claimed |
| US-20030036068-A1 | Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer | ONCOMEDX, INC. | 2003-02-20 | — | — | US | claimed |
| US-20020155469-A1 | Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer | ONCOMEDX, INC. | 2002-10-24 | — | — | US | claimed |
| US-20020106684-A1 | Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer | ONCOMEDX, INC. | 2002-08-08 | — | — | US | claimed |
| US-6329179-B1 | EXTRACTING CIRCULATING RNA FROM BLOOD OR PLASMA AND UTILIZING NUCLEIC ACID AMPLIFICATION TO SCREEN FOR THE PRESENCE OF CANCER OR PRE-CANCER TISSUE; DIAGNOSING CANCER | ONCOMEDX, INC. | 2001-12-11 | — | — | US | claimed |
| US-5958693-A | CYTOLYSIS OF FUNGAL CELLS; FOR NUCLEIC ACIDS OF 28S RIBOSOMAL GENES TO BE USED AS PRIMERS AND PROBES IN DETECTION OF DISEASE IN HUMANS AND ANIMALS AND SPOILAGE OF FOOD AND BEVERAGES | BAYER CORPORATION (US) | 1999-09-28 | — | — | US | claimed |
| US-20240228632-A9 | ANTI-MET ANTIBODIES AND USES THEREOF | Agomab Therapeutics (BE) | 2024-07-11 | — | — | US | disclosed |
| CN-118308348-A | Method for separating non-vesicle miRNA | 凯杰有限公司 | 2024-07-09 | — | — | CN | disclosed |
| CN-111886252-B | Method for promoting growth of islet cells | 阿戈马布治疗有限公司 | 2024-06-18 | — | — | CN | disclosed |
| US-20240132601-A1 | ANTI-MET ANTIBODIES AND USES THEREOF | Agomab Therapeutics (BE) | 2024-04-25 | — | — | US | disclosed |
| CN-117904300-A | Glioma temozolomide drug-resistant diagnostic marker and application thereof | 复旦大学附属华山医院 | 2024-04-19 | — | — | CN | disclosed |
| EP-0642590-A1 | RNA FINGERPRINT ANALYSIS | AMERSHAM INTERNATIONAL plc (GB) | 1995-03-15 | — | — | EP | disclosed |
| WO-1995006415-A1 | SENESCENT CELL-DERIVED INHIBITORS OF DNA SYNTHESIS | BAYLOR COLLEGE OF MEDICINE (US) | 1995-03-09 | — | — | WO | disclosed |
| WO-1994008007-A1 | TROPHIC FACTOR HAVING ION CHANNEL-INDUCING ACTIVITY IN NEURONAL CELLS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1994-04-14 | — | — | WO | disclosed |
| WO-1994004659-A1 | A NOVEL B-LYMPHOMA CELL LINE AND ANTIGEN | UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 1994-03-03 | — | — | WO | disclosed |
| WO-1993024655-A1 | RNA ANALYSIS | AMERSHAM INTERNATIONAL PLC (GB) | 1993-12-09 | — | — | WO | disclosed |